BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.
BioSenic has raised $540K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.
BioSenic's investors include European Investment Bank, Life Sciences Research Partners V.Z.W., BAMS Angel Fund, Nausicaa Ventures.
BioSenic is headquartered in Saintes, Belgium.
BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.
BioSenic is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioSenic — Funding & Investors." VCBacked, February 2, 2024, https://www.vcbacked.co/company/biosenic. Accessed November 13, 2026.
VCBacked. (2024). BioSenic — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/biosenic
{{cite web |title=BioSenic — Funding & Investors |url=https://www.vcbacked.co/company/biosenic |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at BioSenic? Request a listing update